AUPN814496A0
(en)
*
|
1996-02-19 |
1996-03-14 |
Monash University |
Dermal penetration enhancer
|
GB9616237D0
(en)
*
|
1996-08-01 |
1996-09-11 |
Norton Healthcare Ltd |
Aerosol formulations
|
DZ2947A1
(fr)
|
1998-11-25 |
2004-03-15 |
Chiesi Farma Spa |
Inhalateur à compteur de dose sous pression.
|
GB9902689D0
(en)
*
|
1999-02-08 |
1999-03-31 |
Novartis Ag |
Organic compounds
|
DE19921693A1
(de)
*
|
1999-05-12 |
2000-11-16 |
Boehringer Ingelheim Pharma |
Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
|
US20100197719A1
(en)
*
|
1999-05-12 |
2010-08-05 |
Boehringer Ingelheim Pharma Kg |
Medicament compositions containing anticholinergically-effective compounds and betamimetics
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
US7214687B2
(en)
|
1999-07-14 |
2007-05-08 |
Almirall Ag |
Quinuclidine derivatives and medicinal compositions containing the same
|
IT1313553B1
(it)
|
1999-07-23 |
2002-09-09 |
Chiesi Farma Spa |
Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
|
CO5270018A1
(es)
*
|
1999-12-11 |
2003-04-30 |
Glaxo Group Ltd |
Distribuidor de medicamento
|
US6651655B1
(en)
*
|
2000-01-18 |
2003-11-25 |
Quadrant Technologies Limited |
Inhaled vaccines
|
IT1317846B1
(it)
|
2000-02-22 |
2003-07-15 |
Chiesi Farma Spa |
Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
|
GB0008660D0
(en)
*
|
2000-04-07 |
2000-05-31 |
Arakis Ltd |
The treatment of respiratory diseases
|
UA73986C2
(uk)
|
2000-05-22 |
2005-10-17 |
К'Єзі Фармачеутічі С.П.А. |
АЕРОЗОЛЬНА КОМПОЗИЦІЯ, ЩО МІСТИТЬ <font face="Symbol">b</font>2-АДРЕНЕРГІЧНИЙ АГОНІСТ ТРИВАЛОЇ ДІЇ, ДОЗУЮЧИЙ ІНГАЛЯТОР ПІД ТИСКОМ ТА СПОСІБ ЙОГО ЗАПОВНЕННЯ
|
US20060257324A1
(en)
*
|
2000-05-22 |
2006-11-16 |
Chiesi Farmaceutici S.P.A. |
Pharmaceutical solution formulations for pressurised metered dose inhalers
|
FR2812545B1
(fr)
*
|
2000-08-03 |
2003-03-28 |
Air Liquide Sante Int |
Aerosol medicamenteux inhalable dans le traitement ou la prevention de la douceur
|
US20040081627A1
(en)
*
|
2000-10-09 |
2004-04-29 |
Jinks Phillip A |
Medicinal aerosol formulations
|
DZ3478A1
(fr)
*
|
2000-10-12 |
2002-04-18 |
Boehringer Ingelheim Pharma |
Monohydrate cristallin, procede pour sa fabrication et son utilisation pour la fabrication d'un medicament.
|
US6908928B2
(en)
|
2000-10-12 |
2005-06-21 |
Bi Pharma Kg. |
Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
|
US7776315B2
(en)
*
|
2000-10-31 |
2010-08-17 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pharmaceutical compositions based on anticholinergics and additional active ingredients
|
BR0115016A
(pt)
*
|
2000-10-31 |
2005-05-03 |
Boehringer Ingelheim Pharma |
Formulação de solução inalativa com um sal de tiotrópio
|
US6620438B2
(en)
*
|
2001-03-08 |
2003-09-16 |
Boehringer Ingelheim Pharma Kg |
Pharmaceutical compositions based on anticholinergics and NK1-receptor antagonists
|
US20020137764A1
(en)
|
2000-10-31 |
2002-09-26 |
Karin Drechsel |
Inhalable formulation of a solution containing a tiotropium salt
|
US20100310477A1
(en)
*
|
2000-11-28 |
2010-12-09 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg. |
Pharmaceutical compositions based on anticholingerics and additional active ingredients
|
DE10111843A1
(de)
*
|
2001-03-13 |
2002-09-19 |
Boehringer Ingelheim Pharma |
Verbindungen zur Behandlung von inflammatorischen Erkrankungen
|
HU229798B1
(en)
*
|
2001-03-30 |
2014-07-28 |
Jagotec Ag |
Medical aerosol compositions and process for their preparation
|
US20030055026A1
(en)
|
2001-04-17 |
2003-03-20 |
Dey L.P. |
Formoterol/steroid bronchodilating compositions and methods of use thereof
|
US6667344B2
(en)
|
2001-04-17 |
2003-12-23 |
Dey, L.P. |
Bronchodilating compositions and methods
|
US20030013675A1
(en)
*
|
2001-05-25 |
2003-01-16 |
Boehringer Ingelheim Pharma Kg |
Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases
|
US6472563B1
(en)
*
|
2001-11-09 |
2002-10-29 |
Sepracor Inc. |
Formoterol tartrate process and polymorph
|
US6858615B2
(en)
|
2002-02-19 |
2005-02-22 |
Parion Sciences, Inc. |
Phenyl guanidine sodium channel blockers
|
DK3536344T3
(da)
*
|
2002-03-01 |
2020-03-16 |
Chiesi Farm Spa |
Superfin formoterolformulering
|
DE10212264A1
(de)
|
2002-03-20 |
2003-10-02 |
Boehringer Ingelheim Pharma |
Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
|
DE10214263A1
(de)
*
|
2002-03-28 |
2003-10-16 |
Boehringer Ingelheim Pharma |
HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
|
US7244415B2
(en)
*
|
2002-03-28 |
2007-07-17 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
HFA suspension formulations of an anhydrate
|
DE10214264A1
(de)
*
|
2002-03-28 |
2003-10-16 |
Boehringer Ingelheim Pharma |
HFA-Suspensionsformulierungen eines Anhydrats
|
US7311894B2
(en)
|
2002-03-28 |
2007-12-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
HFA suspension formulations containing an anticholinergic
|
GB0207906D0
(en)
|
2002-04-05 |
2002-05-15 |
3M Innovative Properties Co |
Formoterol and mometasone aerosol formulations
|
GB0207899D0
(en)
*
|
2002-04-05 |
2002-05-15 |
3M Innovative Properties Co |
Formoterol and cielesonide aerosol formulations
|
US20050181032A1
(en)
*
|
2002-06-25 |
2005-08-18 |
Acrux Dds Pty Ltd. |
Metastable pharmaceutical compositions
|
US20050186141A1
(en)
*
|
2002-06-25 |
2005-08-25 |
Acrux Dds Pty Ltd. |
Transdermal aerosol compositions
|
WO2004000263A1
(en)
*
|
2002-06-25 |
2003-12-31 |
Acrux Dds Pty Ltd |
Transdermal delivery rate control using amorphous pharmaceutical compositions
|
ES2263051T3
(es)
*
|
2002-12-10 |
2006-12-01 |
Sepracor Inc. |
Uso de l-tartrato de levalbuterol en la produccion de un inhalador de dosis medias.
|
WO2004052374A1
(en)
*
|
2002-12-12 |
2004-06-24 |
Altana Pharma Ag |
Combination medicament
|
US20050058606A1
(en)
*
|
2002-12-16 |
2005-03-17 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Tiotropium containing HFC solution formulations
|
US20040152720A1
(en)
*
|
2002-12-20 |
2004-08-05 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Powdered medicaments containing a tiotropium salt and salmeterol xinafoate
|
CN1292748C
(zh)
*
|
2003-03-05 |
2007-01-03 |
南昌弘益科技有限公司 |
噻托溴铵吸入粉雾剂及其制备工艺
|
AU2004224367B2
(en)
*
|
2003-03-20 |
2009-10-08 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Formulation for a metered dose inhaler using hydro-fluoro-alkanes as propellants
|
CA2525943A1
(en)
*
|
2003-05-22 |
2004-12-02 |
Altana Pharma Ag |
Salmeterol and ciclesonide combination
|
GB0312148D0
(en)
|
2003-05-28 |
2003-07-02 |
Aventis Pharma Ltd |
Stabilized pharmaceutical products
|
WO2004110460A1
(en)
|
2003-06-13 |
2004-12-23 |
Altana Pharma Ag |
Formoterol and ciclesonide combination
|
GB0315889D0
(en)
*
|
2003-07-08 |
2003-08-13 |
Aventis Pharma Ltd |
Stable pharmaceutical products
|
TWI359675B
(en)
|
2003-07-10 |
2012-03-11 |
Dey L P |
Bronchodilating β-agonist compositions
|
US20050026948A1
(en)
*
|
2003-07-29 |
2005-02-03 |
Boehringer Ingelheim International Gmbh |
Medicaments for inhalation comprising an anticholinergic and a betamimetic
|
AU2003254429A1
(en)
*
|
2003-08-06 |
2005-02-25 |
Galephar M/F |
Advantageous combinations for inhalation of nacystelyn and bronchodilators
|
US7745442B2
(en)
|
2003-08-20 |
2010-06-29 |
Parion Sciences, Inc. |
Methods of reducing risk of infection from pathogens
|
AU2004271744B2
(en)
|
2003-09-16 |
2010-07-29 |
Covis Pharma B.V. |
Use of ciclesonide for the treatment of respiratory diseases
|
EP1699435A4
(en)
*
|
2003-09-18 |
2009-05-20 |
Norton Healthcare Ltd |
PARTICLE
|
GB0323684D0
(en)
*
|
2003-10-09 |
2003-11-12 |
Jagotec Ag |
Improvements in or relating to organic compounds
|
GB0323685D0
(en)
*
|
2003-10-09 |
2003-11-12 |
Jagotec Ag |
Improvements in or relating to organic compounds
|
PL1718336T3
(pl)
*
|
2004-02-06 |
2008-11-28 |
Meda Pharma Gmbh & Co Kg |
Nowe połączenie środków antycholinergicznych i beta-mimetyków do leczenia chorób układu oddechowego
|
CA2550848C
(en)
*
|
2004-02-06 |
2013-02-26 |
Meda Pharma Gmbh & Co. Kg |
Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases
|
SI1713473T1
(sl)
|
2004-02-06 |
2013-06-28 |
Meda Pharma Gmbh & Co. Kg |
Kombinacija antiholinergikov in glukokortikoidov za dolgotranjno zdravljenje astme in KOPB
|
US20070185067A1
(en)
*
|
2004-02-27 |
2007-08-09 |
Altana Pharma Ag |
Ciclesonide and glycopyrronium combination
|
EP1595531A1
(en)
|
2004-05-13 |
2005-11-16 |
CHIESI FARMACEUTICI S.p.A. |
Stable pharmaceutical solution formulations for pressurized metered dose inhalers
|
JP2007533706A
(ja)
*
|
2004-04-20 |
2007-11-22 |
ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング |
喫煙患者における呼吸器疾患の治療のためのシクレソニドの使用
|
US20050238632A1
(en)
*
|
2004-04-23 |
2005-10-27 |
Alburty David S |
Propellant formulations
|
SI2708225T1
(sl)
*
|
2004-04-23 |
2019-05-31 |
Cydex Pharmaceuticals, Inc. |
Formulacija DPI, ki vsebuje sulfoalkil eter ciklodekstrin
|
AU2013201437B2
(en)
*
|
2004-04-23 |
2015-09-03 |
Cydex Pharmaceuticals, Inc |
DPI formulation containing sulfoalkyl ether cyclodextrin
|
ES2257152B1
(es)
*
|
2004-05-31 |
2007-07-01 |
Laboratorios Almirall S.A. |
Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
|
ITRM20040268A1
(it)
*
|
2004-05-31 |
2004-08-31 |
Italchimici S P A |
Formulazione farmaceutica di una soluzione stabile di formoterolo per via inalatoria e suo precedimento di preparazione.
|
NZ552869A
(en)
*
|
2004-07-02 |
2010-06-25 |
Boehringer Ingelheim Int |
Aerosol suspension formulations containing TG 227 ea as a propellant, an ipratropium or tiotropium salt and a small amount of free water to stabilise the composition
|
JP3955868B2
(ja)
*
|
2004-12-27 |
2007-08-08 |
株式会社キングジム |
書類等の綴じ具
|
BRPI0519481A2
(pt)
|
2004-12-27 |
2009-02-03 |
Beiersdorf Ag |
glicopirrolato em preparaÇÕes cosmÉticas
|
DE102005029390A1
(de)
*
|
2005-06-23 |
2007-01-04 |
Beiersdorf Ag |
Wirkstoffkombinationen aus Glycopyrroniumbromid und Polyolen
|
GB0501956D0
(en)
*
|
2005-01-31 |
2005-03-09 |
Arrow Internat |
Nebulizer formulation
|
HUE027076T2
(en)
*
|
2005-03-16 |
2016-08-29 |
Meda Pharma Gmbh & Co Kg |
Combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases
|
EP1879571A1
(de)
*
|
2005-04-23 |
2008-01-23 |
Boehringer Ingelheim International GmbH |
Arzneimittelkombination für die inhalation enthaltend neben einem anticholinergikum ein betamimetikum und ein steroid
|
US20060239935A1
(en)
*
|
2005-04-23 |
2006-10-26 |
Boehringer Ingelheim International Gmbh |
Compositions for inhalation
|
AU2006243238B2
(en)
|
2005-05-02 |
2012-05-24 |
Boehringer Ingelheim International Gmbh |
Novel crystalline forms of tiotropium bromide
|
US8435944B2
(en)
*
|
2005-06-03 |
2013-05-07 |
Acrux Dds Pty Ltd. |
Method and composition for transdermal drug delivery
|
US7629331B2
(en)
|
2005-10-26 |
2009-12-08 |
Cydex Pharmaceuticals, Inc. |
Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
|
AU2012200449B2
(en)
*
|
2005-12-21 |
2013-07-25 |
Meda Pharma Gmbh & Co Kg |
Combination of anticholinergics, glucocorticoids, beta2-agonists, PDE4 inhibitor and antileukotriene for the treatment of inflammatory diseases
|
CN101321539B
(zh)
|
2005-12-21 |
2010-09-29 |
Meda制药有限及两合公司 |
用于治疗炎性疾病的抗胆碱能药、糖皮质激素、β2-激动剂、PDE4抑制剂和抗白细胞三烯药的组合
|
DE102006017320A1
(de)
*
|
2006-04-11 |
2007-10-18 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
|
ES2298049B1
(es)
*
|
2006-07-21 |
2009-10-20 |
Laboratorios Almirall S.A. |
Procedimiento para fabricar bromuro de 3(r)-(2-hidroxi-2,2-ditien-2-ilacetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo (2.2.2) octano.
|
EP2101767A2
(en)
*
|
2006-12-07 |
2009-09-23 |
Eli Lilly & Company |
An article comprising prasugrel
|
DE102007002121B4
(de)
*
|
2007-01-10 |
2008-12-11 |
Dräger, Karl-Heinz |
Verwendung eines Flüssiggasgemisches als nichtbrennbares Treibgas zum Feinstverteilen eines Reiz- oder Kampfstoffes
|
CA2608561A1
(en)
*
|
2007-10-29 |
2009-04-29 |
Carl Paluszkiewicz |
Motorcycle wind deflector accessory support
|
EP2100598A1
(en)
*
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
|
EP2100599A1
(en)
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
|
KR101976107B1
(ko)
|
2009-05-29 |
2019-05-09 |
펄 테라퓨틱스 인코포레이티드 |
활성제의 호흡기 전달
|
US8815258B2
(en)
|
2009-05-29 |
2014-08-26 |
Pearl Therapeutics, Inc. |
Compositions, methods and systems for respiratory delivery of two or more active agents
|
TR200907237A2
(tr)
*
|
2009-09-23 |
2011-04-21 |
Bi̇lgi̇ç Mahmut |
Tiotropyum kuru toz kombinasyonu
|
GB0918149D0
(en)
*
|
2009-10-16 |
2009-12-02 |
Jagotec Ag |
Improved medicinal aerosol formulation
|
TR200907914A2
(tr)
*
|
2009-10-20 |
2011-05-23 |
Bi̇lgi̇ç Mahmut |
Kortlkosteroid içeren kuru toz formunda farmasötik bileşim.
|
AR079451A1
(es)
|
2009-12-18 |
2012-01-25 |
Nycomed Gmbh |
Compuestos 3,4,4a,10b-tetrahidro-1h-tiopirano[4,3-c]isoquinolina
|
JP5914354B2
(ja)
*
|
2009-12-23 |
2016-05-11 |
シエシー ファルマセウティチィ ソシエタ ペル アチオニ |
Copd用併用療法
|
WO2011076841A2
(en)
*
|
2009-12-23 |
2011-06-30 |
Chiesi Farmaceutici S.P.A. |
Combination therapy for copd
|
JP5800829B2
(ja)
|
2009-12-23 |
2015-10-28 |
シエシー ファルマセウティチィ ソシエタ ペル アチオニ |
Copd用エアロゾル製剤
|
TR200909790A2
(tr)
*
|
2009-12-25 |
2011-07-21 |
Bi̇lgi̇ç Mahmut |
Tiotropyum, formoterol ve bir kromoglisik asit türevi kombinasyonu içeren kuru toz kombinasyonu.
|
TR200909792A2
(tr)
|
2009-12-25 |
2011-07-21 |
Bi̇lgi̇ç Mahmut |
Tiotropyum, kortikosteroid ve bir kromoglisik asit türevi kombinasyonu içeren kuru toz kombinasyonu
|
TR200909789A2
(tr)
*
|
2009-12-25 |
2011-07-21 |
Bi̇lgi̇ç Mahmut |
Tiotropyum, budesonid ve bir kromoglisik asit türevi kombinasyonu içeren kuru toz kombinasyonu
|
TR200909791A2
(tr)
*
|
2009-12-25 |
2011-07-21 |
Bi̇lgi̇ç Mahmut |
Salmeterol ve flutikazon içeren farmasötik bileşim@
|
US8834931B2
(en)
|
2009-12-25 |
2014-09-16 |
Mahmut Bilgic |
Dry powder formulation containing tiotropium for inhalation
|
TR200909793A2
(tr)
*
|
2009-12-25 |
2011-07-21 |
Bi̇lgi̇ç Mahmut |
Tiotropyum, mometazon ve bir kromoglisik asit türevi kombinasyonu içeren kuru toz kombinasyonu.
|
EP2510928A1
(en)
|
2011-04-15 |
2012-10-17 |
Almirall, S.A. |
Aclidinium for use in improving the quality of sleep in respiratory patients
|
GB201108039D0
(en)
|
2011-05-13 |
2011-06-29 |
Mexichem Amanco Holding Sa |
Compositions
|
JP2014519519A
(ja)
|
2011-06-15 |
2014-08-14 |
タケダ ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新規3,4,4a,10b−テトラヒドロ−1H−チオピラノ[4,3−c]イソキノリン化合物
|
PE20140648A1
(es)
|
2011-06-17 |
2014-05-30 |
Takeda Gmbh |
Novedosos derivados de ftalazinona-pirrolopirimidinacarboxamida
|
AR086745A1
(es)
|
2011-06-27 |
2014-01-22 |
Parion Sciences Inc |
3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
|
GB201117619D0
(en)
|
2011-10-12 |
2011-11-23 |
Mexichem Amanco Holding Sa |
Compositions
|
GB201117621D0
(en)
|
2011-10-12 |
2011-11-23 |
Mexichem Amanco Holding Sa |
Compositions
|
WO2014099673A1
(en)
|
2012-12-17 |
2014-06-26 |
Parion Sciences, Inc. |
3,5-diamino-6-chloro-n-(n-(4-phenylbutyl)carbamimidoyl) pyrazine-2- carboxamide compounds
|
HUE032891T2
(hu)
|
2012-12-17 |
2017-11-28 |
Parion Sciences Inc |
Klórpirazin-karboxamid-származékok nem kielégítõ nyálkahártya-hidratáció által elõsegített megbetegedések kezelésére
|
WO2014113638A1
(en)
*
|
2013-01-17 |
2014-07-24 |
Aer Devices, Inc. |
Multi-use albuterol maintenance therapy formulations and devices therefor
|
SG11201507286QA
(en)
|
2013-03-15 |
2015-10-29 |
Pearl Therapeutics Inc |
Methods and systems for conditioning of particulate crystalline materials
|
GB201306984D0
(en)
|
2013-04-17 |
2013-05-29 |
Mexichem Amanco Holding Sa |
Composition
|
US9102633B2
(en)
|
2013-12-13 |
2015-08-11 |
Parion Sciences, Inc. |
Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds
|
EA033227B1
(ru)
|
2013-12-30 |
2019-09-30 |
КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. |
Находящаяся под давлением стабильная аэрозольная композиция комбинации гликопиррония бромида и формотерола в форме раствора
|
DK3104854T3
(da)
*
|
2014-02-10 |
2020-05-04 |
Respivant Sciences Gmbh |
Mast-celle-stabilisatorer til lungesygdomsbehandling
|
CA2938994A1
(en)
|
2014-02-10 |
2015-08-13 |
Patara Pharma, LLC |
Inhalable formulations of sodium cromolyn with improved bioavailability
|
US10265296B2
(en)
|
2015-08-07 |
2019-04-23 |
Respivant Sciences Gmbh |
Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
|
US10238625B2
(en)
|
2015-08-07 |
2019-03-26 |
Respivant Sciences Gmbh |
Methods for the treatment of mast cell related disorders with mast cell stabilizers
|
ES2866175T3
(es)
|
2015-12-04 |
2021-10-19 |
Mexichem Fluor Sa De Cv |
Composición farmacéutica
|
EP3506893A4
(en)
|
2016-08-31 |
2020-01-22 |
Respivant Sciences GmbH |
CROMOLYNE COMPOSITIONS FOR THE TREATMENT OF CHRONIC COUGH DUE TO IDIOPATHIC PULMONARY FIBROSIS
|
ES2892673T3
(es)
|
2016-09-19 |
2022-02-04 |
Mexichem Fluor Sa De Cv |
Composición farmacéutica que comprende glicopirrolato
|
EP3909582B1
(en)
|
2016-09-19 |
2023-05-24 |
Mexichem Fluor S.A. de C.V. |
Pharmaceutical composition comprising indacaterol
|
AU2017328910B2
(en)
|
2016-09-19 |
2020-04-09 |
Mexichem Fluor S.A. De C.V. |
Pharmaceutical composition
|
EP3522983A4
(en)
|
2016-10-07 |
2020-06-03 |
Respivant Sciences GmbH |
CROMOLYNE-BASED COMPOSITIONS FOR THE TREATMENT OF PULMONARY FIBROSIS
|
WO2018069210A1
(en)
|
2016-10-10 |
2018-04-19 |
Takeda Gmbh |
Tetrahydrofuro[3,4-c]isoquinolines as inhibitors of pde4
|
EA201990605A1
(ru)
*
|
2016-10-14 |
2019-10-31 |
|
Распыляемые композиции тиотропия и формотерола
|
WO2020032910A1
(ru)
*
|
2018-08-10 |
2020-02-13 |
Наталья Николаевна ТИХОНОВСКАЯ |
Фармацевтическая композиция, лекарственное средство и способ лечения бронхолегочных обструктивных заболеваний
|
PE20221439A1
(es)
|
2019-12-02 |
2022-09-21 |
Chiesi Farm Spa |
Lata de acero inoxidable para inhaladores dosificadores presurizados
|
CN112972384B
(zh)
*
|
2019-12-02 |
2022-03-18 |
长风药业股份有限公司 |
一种格隆溴铵和茚达特罗原料药微粉混合物的制备方法
|
WO2023227782A1
(en)
*
|
2022-05-27 |
2023-11-30 |
Chiesi Farmaceutici S.P.A. |
A pharmaceutical formulation for pressurised metered dose inhaler
|
WO2023227781A1
(en)
*
|
2022-05-27 |
2023-11-30 |
Chiesi Farmaceutici S.P.A. |
A pharmaceutical formulation for pressurised metered dose inhaler
|
WO2023227783A1
(en)
*
|
2022-05-27 |
2023-11-30 |
Chiesi Farmaceutici S.P.A. |
A pharmaceutical formulation for pressurised metered dose inhaler
|